Back to search

University of Crete (UOC)

Μελέτη των αιμοδυναμικών επιπτώσεων της συστηματικής αμυλοείδωσης στην αρτηριακή πίεση και στην σκληρία των περιφερικών αγγείων

Abstract

dc:description

Systemic amyloidosis is a rare and heterogeneous disorder characterized by pathological misfolding of specific precursor proteins, leading to the formation of insoluble amyloid fibrils that deposit predominantly in the extracellular space of organs and tissues, progressively resulting in structural damage and functional impairment. The disease may present as localized or systemic, with frequent involvement of the liver, kidneys, peripheral nervous system, and heart. Among the amyloid subtypes associated with cardiac involvement, immunoglobulin light-chain amyloidosis (AL) and transthyretin amyloidosis (ATTR) represent the most clinically significant forms. ATTR is further classified into hereditary (variant ATTR; ATTRv) and wild-type (wtATTR) forms. Cardiac amyloidosis (CA) constitutes a major determinant of morbidity and mortality across subtypes and is increasingly recognized as a complex multisystem condition rather than a purely myocardial disease. Traditionally conceptualized as a restrictive cardiomyopathy, CA represents a systemic manifestation of amyloid deposition in which vascular involvement, autonomic dysfunction, and hemodynamic abnormalities may substantially influence both clinical phenotype and prognosis. Arterial blood pressure patterns, 24-hour ambulatory blood pressure parameters, nocturnal dipping profiles, orthostatic hypotension, and arterial stiffness—as assessed by pulse wave velocity (PWV)—may serve as integrated markers of systemic disease burden and provide insight into the relationship between vascular and myocardial dysfunction. Within this context, the present study aimed to comprehensively investigate the hemodynamic manifestations of patients with cardiac amyloidosis, focusing on three principal domains: (a) arterial blood pressure and 24-hour blood pressure profile (daytime and nighttime blood pressure, variability, pulse pressure, and dipping status), (b) arterial stiffness assessed by carotid–femoral and carotid–radial PWV, and (c) myocardial dysfunction evaluated through echocardiographic parameters, including global longitudinal strain (GLS). A central research question concerned whether vascular involvement and myocardial dysfunction progress in parallel or are mediated through partially independent pathophysiological mechanisms. Primary objectives included comparative assessment between AL and ATTR subtypes regarding their impact on blood pressure regulation, autonomic dysfunction, and arterial stiffness, as well as the association of these parameters with clinical characteristics and outcomes. A prospective observational clinical study was conducted in patients with cardiac amyloidosis who were hospitalized and/or followed at the two tertiary hospitals of Heraklion, Crete. A total of 64 patients with AL and ATTR amyloidosis were enrolled. All participants underwent comprehensive clinical and laboratory evaluation, electrocardiography, transthoracic echocardiography according to international recommendations, and GLS analysis using two-dimensional speckle-tracking imaging. Orthostatic testing, seven-day home blood pressure monitoring, 24-hour ambulatory blood pressure monitoring (ABPM), and arterial stiffness assessment using carotid–femoral and carotid–radial PWV (Complior SP system) under standardized conditions were performed. A control group of 30 individuals matched for age, sex, and cardiovascular risk profile without evidence of amyloidosis was included for comparative analysis. Patients were followed at six-month intervals with repeat echocardiographic and PWV assessments. Therapeutic management was determined exclusively by the treating physicians according to contemporary clinical guidelines and was not influenced by study participation. During the three-year period (2023–2026), 60.9% of participants were male, with a mean age of 62 years. Of the 64 patients, 11 (17.2%) had AL amyloidosis, 23 (35.9%) had wtATTR, and 30 (46.9%) had ATTRv. Within the ATTRv subgroup, three pathogenic transthyretin gene variants were identified (p.Val114Ala, p.Val50Met, and p.Val142Ile), and carriers of pathogenic variants were also included. Arterial hypertension represented the most frequent comorbidity and was more prevalent among wtATTR-CA and AL patients. In 24-hour ABPM, no statistically significant differences in dipping patterns were observed among amyloid subtypes, although non-dipping was the most common profile overall. Orthostatic hypotension was identified in a subset of patients without significant differences between subtypes, though symptoms were more pronounced in AL. Polyneuropathy, gastrointestinal autonomic manifestations, and carpal tunnel syndrome were frequently observed, underscoring the systemic nature of the disease.Following exclusion of asymptomatic mutation carriers, analyses focused on 54 patients with overt cardiac amyloidosis (ATTRv-CA, wtATTR-CA, and AL). Patients with wtATTR-CA were significantly older. Mean systolic and diastolic blood pressure values, both in office measurements and 24-hour monitoring, did not differ significantly between groups. However, 24-hour mean pulse pressure was higher in wtATTR-CA, suggesting increased hemodynamic burden in this subgroup. Functional capacity assessed by the six-minute walk test was significantly reduced in wtATTR-CA. Left ventricular ejection fraction remained preserved on average across groups, whereas GLS revealed subclinical systolic dysfunction. Laboratory analysis demonstrated higher troponin and NT-proBNP levels in AL patients, consistent with more severe myocardial involvement and a less favorable biological profile compared to ATTR subtypes. Longitudinal follow-up demonstrated progressive deterioration in both arterial stiffness and myocardial deformation parameters in CA patients. A significant increase in carotid–femoral and carotid–radial PWV was observed in CA patients compared with controls, accompanied by worsening GLS in the amyloidosis cohort without comparable changes in controls. Correlation analyses between changes in PWV and GLS revealed only weak associations, suggesting that although vascular stiffening and myocardial dysfunction progress concurrently, they may be mediated through partially distinct pathophysiological pathways. In a subgroup analysis of ATTR patients receiving tafamidis therapy, distinct clinical and vascular profiles emerged between ATTRv-CA and wtATTR-CA. ATTRv-CA patients were younger and exhibited better functional capacity and quality of life compared to wtATTR-CA. Increased carotid–radial PWV was observed in ATTRv-CA patients, while no clear correlation between changes in PWV and GLS was identified. At one-year follow-up, rehospitalization and mortality rates differed among subtypes, with worse outcomes observed in wtATTR-CA and particularly in AL, in alignment with the known clinical aggressiveness of AL amyloidosis and the prognostic significance of cardiac involvement. In conclusion, this study demonstrates that patients with cardiac amyloidosis exhibit progressive worsening of both arterial stiffness and subclinical myocardial dysfunction. The relatively weak correlation between PWV progression and GLS deterioration supports the hypothesis that vascular and myocardial involvement, while interconnected, may not represent strictly parallel expressions of a single mechanism but rather overlapping yet partially independent pathological processes. Furthermore, transthyretin genotype appears to influence clinical phenotype, vascular burden, and therapeutic response, reinforcing the importance of individualized risk stratification and management strategies. Future prospective studies with larger cohorts and extended follow-up are warranted to further clarify the mechanistic interplay between vascular and myocardial remodeling and to establish the prognostic and therapeutic implications of arterial stiffness and myocardial strain in cardiac amyloidosis.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Korela, Dafni
  • Κορέλα, Δάφνη

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/61383

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Korela, Dafni; Κορέλα, Δάφνη. Μελέτη των αιμοδυναμικών επιπτώσεων της συστηματικής αμυλοείδωσης στην αρτηριακή πίεση και στην σκληρία των περιφερικών αγγείων. University of Crete (UOC), 2026. http://hdl.handle.net/10442/hedi/61383